» Articles » PMID: 17409226

Ketogenic Diet Metabolites Reduce Firing in Central Neurons by Opening K(ATP) Channels

Overview
Journal J Neurosci
Specialty Neurology
Date 2007 Apr 6
PMID 17409226
Citations 137
Authors
Affiliations
Soon will be listed here.
Abstract

A low-carbohydrate ketogenic diet remains one of the most effective (but mysterious) treatments for severe pharmacoresistant epilepsy. We have tested for an acute effect of physiological ketone bodies on neuronal firing rates and excitability, to discover possible therapeutic mechanisms of the ketogenic diet. Physiological concentrations of ketone bodies (beta-hydroxybutyrate or acetoacetate) reduced the spontaneous firing rate of neurons in slices from rat or mouse substantia nigra pars reticulata. This region is thought to act as a "seizure gate," controlling seizure generalization. Consistent with an anticonvulsant role, the ketone body effect is larger for cells that fire more rapidly. The effect of ketone bodies was abolished by eliminating the metabolically sensitive K(ATP) channels pharmacologically or by gene knock-out. We propose that ketone bodies or glycolytic restriction treat epilepsy by augmenting a natural activity-limiting function served by K(ATP) channels in neurons.

Citing Articles

Impact of the Ketogenic Diet on Neurological Diseases: A Review.

Rubio C, Lopez-Landa A, Romo-Parra H, Rubio-Osornio M Life (Basel). 2025; 15(1).

PMID: 39860011 PMC: 11767209. DOI: 10.3390/life15010071.


Ketosis regulates K ion channels, strengthening brain-wide signaling disrupted by age.

van Nieuwenhuizen H, Chesebro A, Polizu C, Clarke K, Strey H, Weistuch C Imaging Neurosci (Camb). 2024; 2.

PMID: 39664914 PMC: 11633768. DOI: 10.1162/imag_a_00163.


Putative Role of Adenosine A1 Receptors in Exogenous Ketone Supplements-Evoked Anti-Epileptic Effect.

Kovacs Z, Rauch E, DAgostino D, Ari C Int J Mol Sci. 2024; 25(18).

PMID: 39337356 PMC: 11432942. DOI: 10.3390/ijms25189869.


Metabolic Reprogramming of Astrocytes in Pathological Conditions: Implications for Neurodegenerative Diseases.

Cali C, Cantando I, Castillo M, Gonzalez L, Bezzi P Int J Mol Sci. 2024; 25(16).

PMID: 39201607 PMC: 11354244. DOI: 10.3390/ijms25168922.


Multi-omics Mendelian randomization integrating GWAS, eQTL and pQTL data revealed GSTM4 as a potential drug target for migraine.

Sun X, Chen B, Qi Y, Wei M, Chen W, Wu X J Headache Pain. 2024; 25(1):117.

PMID: 39039470 PMC: 11265128. DOI: 10.1186/s10194-024-01828-w.


References
1.
Liss B, Bruns R, Roeper J . Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons. EMBO J. 1999; 18(4):833-46. PMC: 1171176. DOI: 10.1093/emboj/18.4.833. View

2.
Koster J, Sha Q, Nichols C . Sulfonylurea and K(+)-channel opener sensitivity of K(ATP) channels. Functional coupling of Kir6.2 and SUR1 subunits. J Gen Physiol. 1999; 114(2):203-13. PMC: 2230640. DOI: 10.1085/jgp.114.2.203. View

3.
Ashcroft F, Gribble F . ATP-sensitive K+ channels and insulin secretion: their role in health and disease. Diabetologia. 1999; 42(8):903-19. DOI: 10.1007/s001250051247. View

4.
Schwartzkroin P . Mechanisms underlying the anti-epileptic efficacy of the ketogenic diet. Epilepsy Res. 1999; 37(3):171-80. DOI: 10.1016/s0920-1211(99)00069-8. View

5.
Nehlig A . Age-dependent pathways of brain energy metabolism: the suckling rat, a natural model of the ketogenic diet. Epilepsy Res. 1999; 37(3):211-21. DOI: 10.1016/s0920-1211(99)00073-x. View